Remove 2021 Remove Communication Remove Immunization
article thumbnail

As the Prospect of a Vaccine Approaches, Business and Communications Challenges Are Just Around the Corner

Eye on FDA

Vaccination may start next month, but the effects will not occur until after a period following the second dose which would occur in 2021. Vaccination for COVID-19 not only requires business planning, but communications planning in support of the decisions. But first there will be regulatory rites of passage.

article thumbnail

High levels of exposure to COVID virus may reduce protection from vaccination, prior infection: Study

Express Pharma

The study was performed to understand whether the immunity gained after vaccination or a prior infection was less effective or “leaky” in situations where people are exposed to high levels of the virus.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The 2023-2024 Flu Season: What Pharmacists Need to Know

Digital Pharmacist

The 2022-2023 season was a big season for respiratory viruses after mild seasons the previous two years – possibly due in part to the preventative measures that were being taken for COVID-19 prevention in 2020 and 2021. Below are a few ways to help you efficiently communicate with your patients this flu season.

article thumbnail

WHO and UNICEF data show promising signs of immunisation rebounding in some countries

Express Pharma

million children missed out on one or more vaccines delivered through routine immunization services, compared to 24.4 million children in 2021. The vaccine against diphtheria, tetanus, and pertussis (DTP) is used as the global marker for immunization coverage. million zero-dose children in 2021 but remains higher than the 12.9

article thumbnail

COVID-19: Helping to support momentum on antimicrobial innovation

pharmaphorum

To mark World Antimicrobial Awareness Week NovaBiotics’s Deborah O’Neil tells us why 2021 might be the year anti-infective drugs finally demonstrate their economic value. . 2021 could be the year that they demonstrate their economic case. Let’s use Antimicrobial Awareness Week to get that message out. About the author.

article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

The vaccination of patients with AN1792 led to the activation of their immune systems, which started producing endogenous anti-Abeta antibodies. Therefore, active immunotherapy to trigger the immune system to produce sustained levels of endogenous antibodies has now become far more attractive.

article thumbnail

Pharmacy Star Ratings Changes Coming in 2023

Digital Pharmacist

Food and Drug Administration (FDA) announced its approval of the Boostrix vaccine, commonly known as Tdap (combination of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis) for immunization administration during the third trimester of pregnancy to prevent pertussis in infants younger than two months of age. Background.